Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (20518)	5/11/1998 9:04:00 PM
From: Zeuspaul	Respond to of 32384

How significant might the infrastructure aspect be to Ligand? >>"First, CTCL is a relatively small market," Mr. Prior elaborated. "Larger market opportunities for the product are still in clinical development, and, as yet, no partner has been identified to support such development. At this point, we are still supporting an extensive manufacturing infrastructure developed to serve larger markets. Although we intend to sell the infrastructure pending shareholder approval, we will remain the primary customer supporting that manufacturing facility for some time." << same post #reply-2911568 Zeuspaul